Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
This study is currently recruiting participants.
Study NCT00072098 Information provided by National Cancer Institute (NCI)
First Received: November 4, 2003 Last Updated: June 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Metastatic Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
adenovirus vector
interleukin-12 gene
Additional drug interventions recognized in this trial
Interleukin-12
More general drug interventions related to this trial
Adjuvants, Immunologic
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mount Sinai School of Medicine
National Cancer Institute (NCI)
Back to top of Main Content
